App-Quantinova.ai

Reduced Expression of miR-130a-3p Contributes to Endothelial Cell Senescence and Age-dependent Impairment of Neovascularization

Sylvie Dussault - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Microrna-150 Modulates Ischemia-induced Neovascularization in Atherosclerotic Conditions

Dussault Sylvie - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypercholesterolemia, Familial, 1

N/A

Endothelial Calpain Promotes Adverse Cardiac Changes in Mice Fed a High Fat Diet by Impairing Angiogenesis

Xiaomei Teng - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

Nitric oxide

Increased Pulsatile Arterial Load and Progression of Left Ventricular Longitudinal Systolic Dysfunction in Aortic Stenosis: Results From the PROGRESSA Study

Romain Capoulade - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Systolic dysfunction

N/A

Development of Computational Simulation of Pulmonary Autograft Remodeling After Ross Procedure

Ismail El-Hamamsy - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Coronary Revascularization in Patients With Chronic Kidney Disease and Stable Ischemic Heart Disease: Utilization and Association With Long-term Survival

Matthew James - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic kidney disease

N/A

New Insights Into Calcification and Aortic Stenosis Using 4-dimensional Computed Tomography.

Louis Simard - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention - Insights From the CURRENT-OASIS 7 Trial

Darar Al Khdair - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Clopidogrel bisulfate

Altered Epigenetic Signaling in the Coronary Arteries of Patients With Pulmonary Arterial Hypertension: the Role for BRD4 in the Development of Comorbidities

Jolyane Meloche - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Monocrotaline

Computed Tomography of Non-Stenotic Carotid Plaque in Patients with Embolic Stroke of Undetermined Source (ESUS)

Sheldon Derkatch - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Carotid artery stenosis

N/A

OnabotulinumtoxinA Treatment in Post-stroke Lower Limb Spasticity: Long-term Results From a Phase 3 Study

Alberto Esquenazi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

OnabotulinumtoxinA

Inactivated Microglia and Inhibition Neutrophil Infiltration Reduce Brain Injury Following Intracerebral Hemorrhage in Mice

Wenwu Chen - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Intracerebral hemorrhage

Ganciclovir

Physician- Preferences in the Management of Silent Stroke: Results From a Worldwide Survey

Yue Li - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

Aspirin

What Changes Improve Door-to-Needle Times? Results From a Single Center Door-to-Needle Improvement Initiative

Michael D Hill - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Assessment of Home Time Following Acute Ischemic Stroke in Medicare Beneficiaries

Li Liang - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Modifiable Factors Influencing Timely Carotid Endarterectomy among Stroke Prevention Clinic Patients

Aline Bourgoin - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Large Centralized TIA Assessment Unit Associated With Reduction of Recurrent Stroke by up to 70%

Malcolm Maclure - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Prior Antithrombotic Use is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke: Evidence From Get With the Guidelines-stroke

Phyo Myint - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

The Montreal Assessment of Connected Speech Offers Good Psychometric Properties to Monitor Ecological Language Recovery in Post-stroke Aphasia

Josephine Frachon - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Stroke Recurrence Among South Asians With diabetes in Ontario, Canada

Limei Zhou - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Filters

28841 Abstracts